6775912
Last Update Posted: 2025-01-15
Recruiting
All Genders accepted | 18 Years-70 Years |
18 Estimated Participants | No Expanded Access |
Interventional Study | Does not accept healthy volunteers |
Clinical Study on Targeted CD19/BCMA CAR-T Therapy for Autoimmune Diseases
This is an open clinical pharmacological translational Research Study, aiming to evaluate the safety, tolerability, pharmacokinetics, pharmacodynamics and efficacy of RD06-05 in patients with active SLE, SSc, AAV, IIM, NMOSD, MS, MG
Eligibility
Relevant conditions:
SLE
Systemic Sclerosis
IIM
NMOSD
MS
MG
ANCA Associated Vasculitis (AAV)
If you aren't sure if you meet the criteria above speak to your healthcare professional. Criteria may be updated but not reflected here, do not hesitate to contact the trial if you think are close to fitting criteria.
locations
Data sourced from ClinicalTrials.gov